Pfizer has earned a consensus rating of “Moderate Buy” from fifteen analysts, with only one calling it a “sell.” The average ...

Pfizer will pay a $0.43 quarterly dividend on September 2, 2025, maintaining its 347-quarter streak of shareholder payouts.

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

Importantly, Pfizer Inc. (NYSE:PFE) does carry debt. But is this debt a concern to shareholders? We've found 21 US stocks ...

Sector-by-sector analysis throws a spotlight on high-yielding winners in more defensive areas of the stock market.

My final reason for buying more Pfizer stock is that I'll get paid nicely to wait and see if the drugmaker lives up to Wall Street's growth outlook. Pfizer's forward dividend yield currently stands at ...

Pfizer's (NYSE:PFE) stock is up by a considerable 7.5% over the past month. However, we decided to pay attention to ...

InvestingPro has identified several key strengths for Pfizer, including its high shareholder yield and 14-year track record of consecutive dividend increases. With 8 more exclusive ProTips and ...

Verizon Communications. With an attractive dividend yield of 6.19%, Verizon Communications Inc. is a high-yield dividend stock that has become a part of several portfolios.The telecommunications ...

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and why it is a Buy.

Here are three high-yield dividend stocks Wall Street analysts are betting on. Pfizer Pharmaceutical company Pfizer Inc. (NYSE: PFE) saw tremendous highs during the pandemic.